Cholesterol potentiates β-amyloid-induced toxicity in human neuroblastoma cells:: Involvement of oxidative stress

被引:37
作者
Ferrera, Patricia [1 ]
Mercado-Gomez, Octavio [1 ]
Silva-Aguilar, Martin [1 ]
Valverde, Mahara [1 ]
Arias, Clorinda [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico
关键词
cholesterol; beta-amyloid; neurotoxicity; ROS; human neuroblastoma;
D O I
10.1007/s11064-008-9623-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alterations in brain cholesterol concentration and metabolism seem to be involved in Alzheimer's disease (AD). In fact, several experimental studies have reported that modification of cholesterol content can influence the expression of the amyloid precursor protein (APP) and amyloid beta peptide (A beta) production. However, it remains to be determined if changes in neuronal cholesterol content may influence the toxicity of A beta peptides and the mechanism involved. Aged mice, AD patients and neurons exposed to A beta, show a significant increase in membrane-associated oxidative stress. Since A beta is able to promote oxidative stress directly by catalytically producing H2O2 from cholesterol, the present work analyzed the effect of high cholesterol incorporated into human neuroblastoma cells in A beta-mediated neurotoxicity and the role of reactive oxygen species (ROS) generation. Neuronal viability was studied also in the presence of 24S-hydroxycholesterol, the main cholesterol metabolite in brain, as well as the potential protective role of the lipophilic statin, lovastatin.
引用
收藏
页码:1509 / 1517
页数:9
相关论文
共 58 条
[1]   BETA-AMYLOID PEPTIDE FRAGMENT-25-35 POTENTIATES THE CALCIUM-DEPENDENT RELEASE OF EXCITATORY AMINO-ACIDS FROM DEPOLARIZED HIPPOCAMPAL SLICES [J].
ARIAS, C ;
ARRIETA, I ;
TAPIA, R .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 41 (04) :561-566
[2]   β-amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals:: Implications for Alzheimer's disease [J].
Arias, C ;
Montiel, T ;
Quiroz-Báez, R ;
Massieu, L .
EXPERIMENTAL NEUROLOGY, 2002, 176 (01) :163-174
[3]   Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches [J].
Behl, C .
PROGRESS IN NEUROBIOLOGY, 1999, 57 (03) :301-323
[4]   Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes [J].
Bouaïcha, N ;
Maatouk, I .
TOXICOLOGY LETTERS, 2004, 148 (1-2) :53-63
[5]   Co-localization of cholesterol, apolipoprotein E and fibrillar Aβ in amyloid plaques [J].
Burns, MP ;
Noble, WJ ;
Olm, V ;
Gaynor, K ;
Casey, E ;
LaFrancois, J ;
Wang, L ;
Duff', K .
MOLECULAR BRAIN RESEARCH, 2003, 110 (01) :119-125
[6]   The metallobiology of Alzheimer's disease [J].
Bush, AI .
TRENDS IN NEUROSCIENCES, 2003, 26 (04) :207-214
[7]  
Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61
[8]   Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity:: Implications for neurodegeneration in Alzheimer's disease brain.: A review [J].
Butterfield, DA .
FREE RADICAL RESEARCH, 2002, 36 (12) :1307-1313
[9]   Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease [J].
Cutler, RG ;
Kelly, J ;
Storie, K ;
Pedersen, WA ;
Tammara, A ;
Hatanpaa, K ;
Troncoso, JC ;
Mattson, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (07) :2070-2075
[10]   Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo [J].
Fassbender, K ;
Simons, M ;
Bergmann, C ;
Stroick, M ;
Lütjohann, D ;
Keller, P ;
Runz, H ;
Kühl, S ;
Bertsch, T ;
von Bergmannn, K ;
Hennerici, M ;
Beyreuther, K ;
Hartmann, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5856-5861